90679-35-9 Usage
General Description
5-Pyridin-4-yl-1H-indole is a chemical compound that has a pyridine ring attached to an indole group. It is commonly used as a building block in organic synthesis and pharmaceutical research. 5-PYRIDIN-4-YL-1H-INDOLE has been found to have potential therapeutic applications due to its ability to interact with biological systems. It is also known for its role as a ligand in coordination chemistry and its use in the development of new materials. Additionally, 5-Pyridin-4-yl-1H-indole has been studied for its potential use as a fluorescent probe for detecting various biomolecules and as a precursor for the synthesis of complex natural products.
Check Digit Verification of cas no
The CAS Registry Mumber 90679-35-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,6,7 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 90679-35:
(7*9)+(6*0)+(5*6)+(4*7)+(3*9)+(2*3)+(1*5)=159
159 % 10 = 9
So 90679-35-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H10N2/c1-2-13-12(5-8-15-13)9-11(1)10-3-6-14-7-4-10/h1-9,15H
90679-35-9Relevant articles and documents
Rapid Syntheses of Heteroaryl-Substituted Imidazo[1,5-a]indole and Pyrrolo[1,2-c]imidazole via Aerobic C2-H Functionalizations
Kong, Wei-Jun,Chen, Xingrong,Wang, Mingming,Dai, Hui-Xiong,Yu, Jin-Quan
supporting information, p. 284 - 287 (2018/01/17)
Here we report an aerobic Pd(0) catalyzed C2-H functionalization of indoles and pyrroles with tethered N-methoxylamide as the directing group. A Pd(0)-initiated mechanism overcomes the directing or poisoning effect from a wide range of heterocycles including pyridine, pyrimidine, and thiazole. The imidazo[1,5-a]indole products are transformed to bioactive analogs after one-step manipulations, demonstrating the potential utility of this reaction in drug discovery.
NOVEL 2,3-DIHYDROINDOLE COMPOUNDS
-
Page/Page column 21-22, (2010/11/26)
The invention relates to compounds of the formula I, wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
